Compounds > sch 34826

Page last updated: 2024-09-03

sch 34826 and atrial natriuretic factor (4-23)nh2, de-gln(18)-de-ser(19)-de-gly(20,22)-de-leu(21)-

sch 34826 has been researched along with atrial natriuretic factor (4-23)nh2, de-gln(18)-de-ser(19)-de-gly(20,22)-de-leu(21)- in 1 studies

Compound Research Comparison

Studies (sch 34826)	Trials (sch 34826)	Recent Studies (post-2010) (sch 34826)	Studies (atrial natriuretic factor (4-23)nh2, de-gln(18)-de-ser(19)-de-gly(20,22)-de-leu(21)-)	Trials (atrial natriuretic factor (4-23)nh2, de-gln(18)-de-ser(19)-de-gly(20,22)-de-leu(21)-)	Recent Studies (post-2010) (atrial natriuretic factor (4-23)nh2, de-gln(18)-de-ser(19)-de-gly(20,22)-de-leu(21)-)
31	2	0	60	1	4

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brown, A; Chiu, PJ; Griscti, K; Sybertz, EJ; Vemulapalli, S	1

Other Studies

1 other study(ies) available for sch 34826 and atrial natriuretic factor (4-23)nh2, de-gln(18)-de-ser(19)-de-gly(20,22)-de-leu(21)-

Article	Year
The blood pressure and renal responses to SCH 34826, a neutral metalloendopeptidase inhibitor, and C-ANF (4-23) in Doca-salt hypertensive rats. Life sciences, 1991, Volume: 49, Issue:5 Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Desoxycorticosterone; Dioxolanes; Dipeptides; Hypertension; Kidney; Male; Neprilysin; Peptide Fragments; Rats	1991